The IPO provides BlossomHill with approximately $150M in gross proceeds to fund operations and pipeline development. Monitor upcoming quarterly filings for cash runway, R&D spend, and pipeline progress — no earnings or guidance were provided in this filing.
Price Chart
Executive Summary
BlossomHill Therapeutics completed its IPO on August 10, 2026, selling 9,375,000 shares at $16.00 per share for gross proceeds of approximately $150 million. The filing also covers the adoption of post-IPO amended and restated certificate of incorporation and bylaws, which include standard public company governance provisions such as a classified board, supermajority voting requirements for certain amendments, and exclusive forum clauses. This is a routine post-IPO administrative filing with no new operational or financial disclosures beyond the IPO completion.
Key Facts
- IPO closed on August 10, 2026
- 9,375,000 shares sold at $16.00 per share
- Gross proceeds of approximately $150.0 million
- Amended and restated certificate of incorporation and bylaws adopted effective upon IPO closing
- Authorized capital stock increased to 700M shares of common stock and 10M shares of preferred stock
- Governance provisions include classified board, supermajority vote requirements, and exclusive forum clauses
Financial Impact
IPO raised approximately $150 million in gross proceeds
Risk Factors
- No financial results or pipeline updates disclosed in this filing
- Post-IPO lockup expiration could create near-term selling pressure
- Governance provisions (classified board, supermajority votes) may deter activist activity
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-342316 |
| Document: d138762d8k.htm | 0001193125-26-342316 |
| Document: 0001193125-26-342316-index-headers.html | 0001193125-26-342316 |
| Document: 0001193125-26-342316-index.html | 0001193125-26-342316 |
| Document: 0001193125-26-342316.txt | 0001193125-26-342316 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 28, 2026 28d ago | Press Release | $21.34 $16.39 | ▲ +23.20% | ▲ +23.16% | $16.39 (+23.20%) |
Sep 18, 2026 5w ago | 8-K | $25.74 $13.94 | ▲ +45.84% | ▲ +46.05% | $16.39 (+36.32%) |
Sep 18, 2026 5w ago | Press Release | $25.74 $13.94 | ▼ −45.84% | ▼ −46.05% | $16.39 (−36.32%) |
Sep 15, 2026 5w ago | 8-K | $22.17 $15.48 | ▼ −30.18% | ▼ −33.15% | $16.39 (−26.07%) |
Aug 12, 2026 10w ago | Insider Cluster | $16.35 $20.86 | ▲ +27.58% | ▲ +29.33% | $16.39 (+0.24%) |
Aug 10, 2026 10w ago | Insider Cluster | $16.52 $22.00 | ▲ +33.17% | ▲ +34.23% | $16.39 (−0.79%) |
Aug 10, 2026 11w ago | 8-K | $16.52 $22.00 | ▲ +33.17% | ▲ +34.23% | $16.39 (−0.79%) |
Aug 7, 2026 11w ago | 424B4 | $15.99 $22.93 | ▲ +43.40% | ▲ +44.32% | $16.39 (+2.50%) |
Aug 7, 2026 11w ago | EFFECT | $16.00 $22.01 | ▲ +37.56% | ▲ +37.96% | $16.39 (+2.44%) |
Aug 6, 2026 11w ago | 3 | $16.00 $22.01 | ▲ +37.56% | ▲ +37.96% | $16.39 (+2.44%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers